Skip to content

Underwater Versus Conventional Endoscopic Mucosal Resection in the Treatment of Non-pedunculated Colorectal Polyps

Comparison of the Efficiency and Safety of Underwater Endoscopic Mucosal Resection and Conventional Endoscopic Mucosal Resection in the Treatment of Non-pedunculated Colorectal Polyps

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05825664
Enrollment
228
Registered
2023-04-24
Start date
2023-04-07
Completion date
2024-07-31
Last updated
2023-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Polyp, Colorectal Neoplasms

Keywords

colorectal polyp, underwater endoscopic mucosal resection, conventional endoscopic mucosal resection

Brief summary

A prospective, randomized, controlled study to compare the efficacy and safety of underwater endoscopic mucosal resection and conventional endoscopic mucosal resection in removal of non-pedunculated colorectal polyps

Detailed description

* Patients are undergone colonoscopy at the Endoscopy department of Ho Chi Minh City University Medical Center. * Randomize patients with non-pedunculated polyp of 10mm or larger in size into 2 interventional groups based on Random function of Statistical Package for the Social Sciences (SPSS) 20.0, including (1) Group 1: Underwater endoscopic mucosal resection (UEMR) and (2) Group 2: Conventional endoscopic mucosal resection (CEMR). * The time of local recurrence assessment depends on the histopathology of polyps. Polyps with low grade dysplasia are followed up at 6 months, while polyps with high grade dysplasia are followed at 3 months. * Collecting variables which consist of primary and secodary outcomes.

Interventions

Group 1: Polyps are resected by UEMR Group 2: Polyps are resected by CEMR

Sponsors

University of Medicine and Pharmacy at Ho Chi Minh City
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * Non-pedunculated polyps of 10 mm or more in size * Type 1 or 2 according to NBI International Colorectal Endoscopy (NICE) classification * Patients must sign an informed consent form prior to registration in study

Exclusion criteria

* Lesions with signs of deep invasion (hard, friable tissue, poor mobility, positive non-lifting sign) * Type 3 according to NICE classification * Colorectal cancer * Patients with unstable chronic disease (melitus diabetes, hypertension, heart failure, kidney failure, liver failure, chronic obstructive pulmonary disease) * Hemostasis disorder (INR \> 1.5; platelets \< 100000/mm3)

Design outcomes

Primary

MeasureTime frameDescription
en bloc resectionimmediately after the procedureRate of en bloc resection for non-pedunculated colorectal polyps of 10 mm or more
Curative ratethrough study completion, an average of 6 monthsCurative rate for non-pedunculated colorectal polyps of 10 mm or more

Secondary

MeasureTime frameDescription
Complication rateup to 2 weeksRate of complications including bleeding, perforation
Local recurrence rate6 monthsRate of local recurrence
Procedure timeduring the procedureTime for complete resection of polyps

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026